SCHEMBL13487185

SCHEMBL13487185

CC1(C)c2ccccc2-c2c(-c3c4ccccc4c(-c4ccc5nc(-c6ccccc6)c(-c6ccccc6)nc5c4)c4ccc(-c5cccc6ccccc56)cc34)cccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.36
KDM4E B2RXH2 6/20 0.36
L3MBTL1 Q9Y468 5/20 0.36
LMNA P02545 4/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
KMT2A Q03164 1/20 0.33
ATM Q13315 1/20 0.33
TLR9 Q9NR96 1/20 0.33
TDP1 Q9NUW8 3/20 0.32
GAA P10253 2/20 0.32
HPGD P15428 2/20 0.32
MCL1 Q07820 1/20 0.32
ACMSD Q8TDX5 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
HTT P42858 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
THRB P10828 1/20 0.31
CHRNA1 P02708 1/20 0.31
CHRNG P07510 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13487118 0.93 KDM4E (0.38) ALDH1A1KDM4EL3MBTL1LMNASMN1; SMN2
SCHEMBL13487182 0.92 TDP1 (0.36) ALDH1A1KDM4EL3MBTL1LMNASMN1; SMN2
SCHEMBL13487986 0.92 ALDH1A1 (0.37) ALDH1A1KDM4EL3MBTL1LMNASMN1; SMN2
SCHEMBL13487609 0.92 ALDH1A1 (0.37) ALDH1A1KDM4EL3MBTL1LMNASMN1; SMN2
SCHEMBL13487295 0.91 KDM4E (0.35) ALDH1A1KDM4EL3MBTL1LMNASMN1; SMN2
SCHEMBL13487375 0.91 ALDH1A1 (0.36) ALDH1A1KDM4EL3MBTL1LMNASMN1; SMN2
SCHEMBL13487057 0.89 ALDH1A1 (0.47) ALDH1A1KDM4EL3MBTL1LMNASMN1; SMN2
SCHEMBL13487987 0.87 TDP1 (0.35) ALDH1A1KDM4EL3MBTL1LMNASMN1; SMN2
SCHEMBL13487608 0.87 TDP1 (0.35) ALDH1A1KDM4EL3MBTL1LMNASMN1; SMN2
SCHEMBL13487116 0.85 TDP1 (0.38) ALDH1A1KDM4EL3MBTL1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 ALDH1A1 101/4885KDM4E 3671/4885L3MBTL1 1193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.